Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin in localized small cell lung carcinoma
2004-004722-27Phase 2Terminated
- Sponsor
- Instituto CientÃfico y Tecnológico de Navarra, S.A.
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bemiparin in small cell lung cancer (SCLC) (2 arms), sponsored by Instituto CientÃfico y Tecnológico de Navarra, S.A. Primary endpoint: Progression-free survival. Started Apr 2006; status: terminated.
02
Drugs
bemiparin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2004-004722-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004722-27.